
Ondansetron Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL
Reference Brands: Zofran(US & EU)
Category: Oncology Cancer Care
Ondansetron Injection is available in Injection and strengths such as 2 mg/2 mL, 4 mg/2 mL , 8 mg/4 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ondansetron Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ondansetron Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Ondansetron Injection 2 mg/2 mL, 4 mg/2 mL, and 8 mg/4 mL is an essential medication in oncology for the prevention of chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). As a 5-HT3 receptor antagonist, it effectively blocks serotonin, reducing nausea and vomiting associated with highly emetogenic chemotherapy. Ondansetron is available in IV solution form and is widely used in oncology B2B distribution across the U.S. and EU. It plays a vital role in improving patient comfort during cancer treatment.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers